Viewing data from:

COLISTIMETHATE SODIUM

ANDA

COLISTIMETHATE SODIUM | A064216 | PHARMOBEDIENT CONSULTING LLC

1 strength0 unique patents0 unique exclusivities

API Supply Chain3 active DMFs

3 active API suppliers hold Drug Master Files for this ingredient.

XELLIA PHARMACEUTICALS APSCOLISTIMETHATE SODIUM USP

DMF 133631998

LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTDCOLISTIMETHATE SODIUM

DMF 283502014

HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO LTDCOLISTIMETHATE SODIUM

DMF 351772020

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Feb 26, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 150MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Feb 26, 1999

No patent or exclusivity listings for this strength.